CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...
Phase 2
Milan, Italy and 56 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Milan, Milano, Italy and 89 other locations
To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...
Milano, Italy and 89 other locations
The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D)....
Phase 1, Phase 2
Milan, Italy and 15 other locations
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Phase 3
Milano, Italy and 185 other locations
the treatment with Usual Care alone, for the healing of chronic diabetic foot ulcer. VULNOFAST® plus is a sterile solution used in combinati...
Milano, Italy and 6 other locations
This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired aw...
Phase 3
Milan, Italy and 28 other locations
The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or ov...
Phase 3
Milan, Italy and 147 other locations
β-cell function in participants with recently diagnosed type 1 diabetes (T1D) on insulin therapy.The study design comprises 2 parts: in Part...
Phase 2
Milan, Milano, Italy and 18 other locations
This study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a n...
Phase 3
Milano, Italy and 46 other locations
Clinical trials
Research sites
Resources
Legal